ArticleFrontiers in pharmacology2022

A Combined Pharmacometrics Analysis of Biomarker Distribution Under Treatment With Standard- or Low-Dose Rivaroxaban in Real-World Chinese Patients With Nonvalvular Atrial Fibrillation.

Nan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.